Caleb T Cross, Rentse Gj De Jong, Sunny P Horner, Jordan L Johnston, Cole D Davidson
Pancreatic cancer is an aggressive malignancy with poor survival and limited treatment options, highlighting the need for novel therapies. Bavachin, a naturally occurring compound derived from Psoralea corylifolia , has demonstrated anticancer activity in other cancer models. We evaluated the effects of bavachin on PANC-1 pancreatic cancer cells in vitro . Sulforhodamine B and trypan blue assays assessed cell viability and determined the IC₅₀, while a wound healing assay evaluated migration. Bavachin significantly reduced PANC-1 cell viability (IC₅₀ = 30.30 μM) and inhibited migration, providing evidence that bavachin affects viability and ability to migrate in PANC-1 cells.